- Home
- BKYI vs ALBT Comparison
BKYI vs ALBT Comparison
Compare BKYI & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKYI
- ALBT
- Stock Information
- Founded
- BKYI 1993
- ALBT 2014
- Country
- BKYI United States
- ALBT United States
- Employees
- BKYI N/A
- ALBT N/A
- Industry
- BKYI Computer Software: Prepackaged Software
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BKYI Technology
- ALBT Health Care
- Exchange
- BKYI Nasdaq
- ALBT Nasdaq
- Market Cap
- BKYI 3.2M
- ALBT 3.2M
- IPO Year
- BKYI 1997
- ALBT N/A
- Fundamental
- Price
- BKYI $0.94
- ALBT $3.15
- Analyst Decision
- BKYI
- ALBT
- Analyst Count
- BKYI 0
- ALBT 0
- Target Price
- BKYI N/A
- ALBT N/A
- AVG Volume (30 Days)
- BKYI 6.3M
- ALBT 2.0M
- Earning Date
- BKYI 11-14-2024
- ALBT 11-12-2024
- Dividend Yield
- BKYI N/A
- ALBT N/A
- EPS Growth
- BKYI N/A
- ALBT N/A
- EPS
- BKYI N/A
- ALBT N/A
- Revenue
- BKYI $7,292,394.00
- ALBT N/A
- Revenue This Year
- BKYI N/A
- ALBT N/A
- Revenue Next Year
- BKYI $24.64
- ALBT N/A
- P/E Ratio
- BKYI N/A
- ALBT N/A
- Revenue Growth
- BKYI N/A
- ALBT N/A
- 52 Week Low
- BKYI $0.52
- ALBT $2.11
- 52 Week High
- BKYI $4.50
- ALBT $21.60
- Technical
- Relative Strength Index (RSI)
- BKYI 45.22
- ALBT 49.01
- Support Level
- BKYI $1.13
- ALBT $2.97
- Resistance Level
- BKYI $1.31
- ALBT $3.69
- Average True Range (ATR)
- BKYI 0.17
- ALBT 0.50
- MACD
- BKYI -0.01
- ALBT 0.01
- Stochastic Oscillator
- BKYI 1.93
- ALBT 40.31
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.